期刊文献+

乳腺癌家族史与绝经后乳腺癌临床病理因素的关系及对预后的影响 被引量:1

Relationship between family history of breast cancer and clinicopathological factors in postmenopausal breast cancer and its influence on prognosis
在线阅读 下载PDF
导出
摘要 目的探讨乳腺癌家族史(family history,FH)与绝经后乳腺癌临床病理因素及生存预后的关系。方法根据有无家族史,将240例行手术治疗的绝经后乳腺癌患者分成FH(+)组和FH(-)组,分析2组临床病理特征及预后情况。结果240例患者中FH(+)者25例(10.4%)。与FH(-)组比较,FH(+)组平均发病年龄低,ER/PR阴性率、Her-2阳性率较高,差异均有统计学意义(P<0.05)。Kaplain-Meier曲线(log-rank检验)结果显示,乳腺癌家族史对绝经后乳腺癌患者OS的影响有统计学意义(χ^(2)=15.772,P<0.001)。多因素Cox回归分析结果显示,Her-2阳性、FH是乳腺癌患者生存预后的危险因素(P<0.05),ER阳性是其保护性因素(P<0.05)。结论绝经后乳腺癌家族史阳性者发病年龄更轻,Her-2阳性、乳腺癌家族史是乳腺癌患者生存预后的危险因素,ER阳性是乳腺癌患者生存预后的保护因素。 Objective To explore the relationship between family history(FH)of breast cancer and clinicopathological factors forpostmenopausal breast cancer and its influence on prognosis.Methods A total of 240 postmenopausal breast cancer patients who underwent surgical treatment for breast cancer were divided into FH(+)group and FH(-)group according to the family history,and the clinicopathological characteristics and prognosis between two groups were compared.Results Of the 240 postmenopausal breast cancer patients,25(10.4%)had a positive family history.The average age of onset in the FH(+)group was lower,the negative rate of ER/PR,and the positive rate of Her-2 were higher than those in the FH(-)group,and the differences were statistically significant(P<0.05).Kaplain-Meier survival analysis and log-rank test showed that the family history of breast cancer had a statistically significant effect on the OS of postmenopausal breast cancer patients(χ^(2)=15.772,P<0.001).Multivariate Cox risk regression analysis showed that the positive expression of Her-2 and positive family history were risk factors for the prognosis in postmenopausal breast cancer patients,while the positive ER was a protective factor.Conclusions A positive family history of post-menopausal breast cancer is associated with a younger age of onset.The positive expression of Her-2 and a family history of breast cancer are risk factors for the survival prognosis of breast cancer patients,while the positive of ER is a protective factor for breast cancer.
作者 王昭君 陈美华 马海广 张祥建 许践刚 WANG Zhaojun;CHEN Meihua;MA Haiguang;ZHANG Xiangjian;XU Jiangang(Department of Oncological Surgery,Wenzhou Central Hospital,Wenzhou 325000,China)
出处 《健康研究》 CAS 2021年第4期423-427,共5页 Health Research
基金 温州市科技局科技计划项目(Y20190754)。
关键词 乳腺癌 绝经后 家族史 预后 breast cancer postmenopausal family history prognosis
  • 相关文献

参考文献10

二级参考文献78

  • 1张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量:29
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:165
  • 3阚秀 赵蕊 等.国人与美、日等国妇女乳腺癌的临床病理对比[J].中国肿瘤临床,1987,14:262-5.
  • 4野水整 柿沼雄二 等.癌家族历上乳癌.第四届日本乳癌学会总会论文摘要[M].,1996,6(26)..
  • 5Mohammed S N,Smith P,Hodgson S N,et al.Family history and survival in premenopausal breast cancer[J].BrJ Cancer,1998,77(12):2252-2256.
  • 6Eccles D,Simmonds P,Goddard T,et al.Familial Breast Cancer:an investigation into the outcome of treatment for early stage disease[J].Fam Cancer,2001,1 (2):65-72.
  • 7陈灿明.乳腺癌病理学进展[A].沈镇宙,邵志敏.现代乳腺肿瘤学进展[C].上海:上海科学技术文献出版社,2004:56-78.
  • 8Tada T,Kasumi F.Characteristics of familial breast cancer[J].Nippon Riusho,2000,58(7):1405-1408.
  • 9Geoffrey L R.Predisposition of breast cancer[A].Kelly K H,Geoffrey L R.Breast Cancer[C].New York:Springer-Verlag New York Inc,2001:55-92.
  • 10Takayuki K,Takashi F,Akashi S,et al.Prognosis of breast cancer patients with familial history classified acorrding to their menopausal status[J].Breast J,2004,10(3):218-221.

共引文献1894

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部